Stay updated on Resmetirom in NASH and Fibrosis Clinical Trial

Sign up to get notified when there's something new on the Resmetirom in NASH and Fibrosis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Resmetirom in NASH and Fibrosis Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    New trial sites were added in Roma, Milano, Palermo, Novara, Messina and Brussels Capital in Belgium, along with Budapest. Some previously listed locations were removed or reformatted (e.g., Brussels, Belgium; Messina, Italy; Novara, Italy) to reflect updated site naming.
    Difference
    0.9%
    Check dated 2026-05-14T14:18:46.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    22 days ago
    Change Detected
    Summary
    A new revision label v3.5.3 was added, replacing the previous v3.5.2 in the page header. This indicates an internal update to the page version without altering visible content.
    Difference
    0.0%
    Check dated 2026-04-30T04:55:28.000Z thumbnail image
  4. Check
    29 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    The page now lists the Vienna location with the more specific label “State of Vienna, Vienna, Austria.” The displayed site revision/version number has also been updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-21T15:57:46.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    Added a publication citation for MAESTRO-NASH (Schattenberg et al., J Hepatol) and removed MedlinePlus Genetics as a related topic.
    Difference
    0.1%
    Check dated 2026-03-31T02:11:54.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0 on the Study Details page.
    Difference
    0.0%
    Check dated 2026-03-23T20:53:02.000Z thumbnail image
  8. Check
    73 days ago
    Change Detected
    Summary
    Added the related topic 'Non-alcoholic fatty liver disease' to the study page and updated the revision from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-09T14:11:38.000Z thumbnail image

Stay in the know with updates to Resmetirom in NASH and Fibrosis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Resmetirom in NASH and Fibrosis Clinical Trial page.